Home/Filings/4/0001140361-25-027404
4//SEC Filing

Shepard Kirk V. 4

Accession 0001140361-25-027404

CIK 0001472091other

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 6:12 PM ET

Size

5.3 KB

Accession

0001140361-25-027404

Insider Transaction Report

Form 4
Period: 2025-06-12
Shepard Kirk V.
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2025-06-12+150,000150,000 total
    Exercise: $1.79Exp: 2035-06-12Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Issuer

PDS Biotechnology Corp

CIK 0001472091

Entity typeother

Related Parties

1
  • filerCIK 0002009007

Filing Metadata

Form type
4
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 6:12 PM ET
Size
5.3 KB